Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells

被引:35
作者
Yang, H. [1 ]
Fu, J-H [1 ]
Hu, Y. [1 ]
Huang, W-Z [1 ]
Zheng, B. [1 ]
Wang, G. [1 ]
Zhang, X. [1 ]
Wen, J. [1 ]
机构
[1] Sun Yat Sen Univ, Dept Thorac Oncol, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China
关键词
lung cancer; apoptosis; survivin; drug therapy; drug resistance; chemosensitivity; RNA interference; siRNA;
D O I
10.1177/147323000803600416
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We investigated the difference in survivin expression between a multidrug-resistant lung cancer cell line (H460/cDDP) and its parental counterpart (H460) and the influence of siRNA targeting survivin on the chemosensitivity of H460/cDDP. SiRNA targeting survivin was transfected into H460/cDDP cells using a liposome approach. Survivin mRNA and protein expression were significantly higher in H460/cDDP than H460 cells. The median inhibitory concentrations (IC(50)s) for cisplatin and paclitaxol in vitro against H460/cDDP cells were significantly lower in cells treated with survivin-specific siRNA than in control cells. Apoptosis and cleaved caspase-3 expression were analysed using annexin V and Western blotting, respectively, and showed a significant increase in apoptosis after treatment with the chemotherapeutic agents plus specific siRNA. Specific siRNA sensitized H460/cDDP cells to both cisplatin and paclitaxol. Thus, survivin appears to participate in the multidrug resistance mechanism of H460/cDDP cells and siRNA targeting survivin has the potential to increase the sensitivity of drug-resistant cancer cells to anticancer drugs.
引用
收藏
页码:734 / 747
页数:14
相关论文
共 34 条
[1]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[2]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[3]   Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis [J].
Chawla-Sarkar, M ;
Bae, SI ;
Reu, FJ ;
Jacobs, BS ;
Lindner, DJ ;
Borden, EC .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (08) :915-923
[4]   Survivin gene expression in early-stage non-small cell lung cancer [J].
Falleni, M ;
Pellegrini, C ;
Marchetti, A ;
Oprandi, B ;
Buttitta, F ;
Barassi, F ;
Santambrogio, L ;
Coggi, G ;
Bosari, S .
JOURNAL OF PATHOLOGY, 2003, 200 (05) :620-626
[5]  
Fink D, 1998, CLIN CANCER RES, V4, P1
[6]  
Giodini A, 2002, CANCER RES, V62, P2462
[7]   Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 [J].
Hoffman, WH ;
Biade, S ;
Zilfou, JT ;
Chen, JD ;
Murphy, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (05) :3247-3257
[8]  
Ikehara M, 2002, ONCOL REP, V9, P835
[9]   Cancer statistics, 2006 [J].
Jemal, A ;
Siegel, R ;
Ward, E ;
Murray, T ;
Xu, JQ ;
Smigal, C ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) :106-130
[10]  
Karczmarek-Borowska B, 2005, FOLIA HISTOCHEM CYTO, V43, P237